Coca-Cola has struggled to integrate its $5.6 billion purchase of BodyArmor with Powerade, which led to more “disruption in the short-term” than expected, according to CEO James Quincey.
Body Armor’s sales declined in the latest quarter.
The Atlanta-based Coca-Cola is optimistic that BodyArmor will eventually complement Powerade, its other big offering in the sports-drink category, as it aims to better compete against industry heavyweight, Pepsi-owned Gatorade.
BodyArmor’s purchase is the largest acquisition in Coca-Cola’s history.
In 2018, Coca-Cola first paid an undisclosed sum for a 15% share in BodyArmor, which had revenues of around $250 million.
That amount increased to more than $1 billion in 2021 when it acquired the remaining shares of brand to increase the variety of beverages it offers.
Through the use of coconut water, low sodium and high potassium levels, the lack of artificial colors, and the addition of sugar in place of high fructose corn syrup, the fast-growing, healthier sports drink gained popularity among consumers.
The purchase of BodyArmor by Coca-Cola led to a big bet that the beverage would play a key role in building out its liquid offerings and repositioning the business into a “total beverage company.”
Coca-Cola’s U.S. sports-drink market share had slipped in recent months. Still, the Coke chief remains optimistic this year will be a turning point for BodyArmor.


Gold Prices Dip as Markets Absorb Dovish Fed Outlook; Silver Eases After Record High
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
S&P 500 Slides as AI Chip Stocks Tumble, Cooling Tech Rally
Fed Rate Cut Signals Balance Between Inflation and Jobs, Says Mary Daly
Gold Prices Slip Slightly in Asia as Silver Nears Record Highs on Dovish Fed Outlook
Ireland Limits Planned Trade Ban on Israeli Settlements to Goods Only
EssilorLuxottica Bets on AI-Powered Smart Glasses as Competition Intensifies
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Asian Stocks Slip as Oracle Earnings Miss Sparks AI Profitability Concerns
Hong Kong Cuts Base Rate as HKMA Follows U.S. Federal Reserve Move
Asian Stocks Slip Ahead of Fed Decision as China Deflation Concerns Deepen
Nvidia Develops New Location-Verification Technology for AI Chips
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
SpaceX Edges Toward Landmark IPO as Elon Musk Confirms Plans
SK Hynix Considers U.S. ADR Listing to Boost Shareholder Value Amid Rising AI Chip Demand
LA28 Confirms Olympic Athletes Exempt from Trump’s Travel Ban
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 



